Omega Advisors’s Insmed INSM Stock Holding History

Omega Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-95,000	Closed	-$2.25M	–	57
2018 Q2	$2.25M	Sell	95,000 -3,000	-3%	-$77.2K	0.08%	65
2018 Q1	$2.21M	Sell	98,000 -57,000	-37%	-$1.5M	0.08%	74
2017 Q4	$4.83M	Buy	155,000 +5,000	+3%	+$148K	0.18%	58
2017 Q3	$4.68M	Buy	+150,000	New	+$2.86M	0.18%	69
2015 Q2	–	Sell	-75,000	Closed	-$1.56M	–	112
2015 Q1	$1.56M	Buy	+75,000	New	+$1.32M	0.02%	91

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

Omega Advisors's INSM Position: Q3 2018 in Review

Omega Advisors sold out of Insmed (INSM) in Q3 2018, closing a stake of 95,000 shares — an estimated $2.25M sold.

Omega Advisors first reported a position in INSM in Q1 2015 and held it in 5 quarters. The position peaked at $4.83M in Q4 2017. 123 funds tracked by Wall St. Rank hold INSM as of Q3 2018.

Omega Advisors reported no remaining Insmed position as of Q3 2018 after selling out during the quarter.
Omega Advisors sold 95,000 Insmed shares in Q3 2018, an estimated $2.25M.
Omega Advisors first reported a position in Insmed in Q1 2015 and held it in 5 quarters.
Omega Advisors's Insmed position peaked at $4.83M in Q4 2017.
123 funds tracked by Wall St. Rank held Insmed as of Q3 2018.

Based on Omega Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.